These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23786804)

  • 21. Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases.
    Koch HW; Larsen M; Bartsch H; Kurz KD; Hofvind S
    Eur Radiol; 2023 May; 33(5):3735-3743. PubMed ID: 36917260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of mammographic density and its influential factors among Chinese women.
    Dai H; Yan Y; Wang P; Liu P; Cao Y; Xiong L; Luo Y; Pan T; Ma X; Wang J; Yang Z; Liu X; Chen C; Huang Y; Li Y; Wang Y; Hao X; Ye Z; Chen K
    Int J Epidemiol; 2014 Aug; 43(4):1240-51. PubMed ID: 24639441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes.
    Nickson C; Arzhaeva Y; Aitken Z; Elgindy T; Buckley M; Li M; English DR; Kavanagh AM
    Breast Cancer Res; 2013; 15(5):R80. PubMed ID: 24020331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic density and estimation of breast cancer risk in intermediate risk population.
    Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
    Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
    Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
    Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography.
    Weber RJ; van Bommel RM; Louwman MW; Nederend J; Voogd AC; Jansen FH; Tjan-Heijnen VC; Duijm LE
    Breast Cancer Res Treat; 2016 Aug; 158(3):471-83. PubMed ID: 27393617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
    van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
    J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
    Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
    Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Birth weight, childhood body mass index, and height in relation to mammographic density and breast cancer: a register-based cohort study.
    Andersen ZJ; Baker JL; Bihrmann K; Vejborg I; Sørensen TI; Lynge E
    Breast Cancer Res; 2014 Jan; 16(1):R4. PubMed ID: 24443815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics.
    Bertrand KA; Scott CG; Tamimi RM; Jensen MR; Pankratz VS; Norman AD; Visscher DW; Couch FJ; Shepherd J; Chen YY; Fan B; Wu FF; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
    Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):798-809. PubMed ID: 25716949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.
    Kim EY; Chang Y; Ahn J; Yun JS; Park YL; Park CH; Shin H; Ryu S
    Cancer; 2020 Nov; 126(21):4687-4696. PubMed ID: 32767699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harms of Restrictive Risk-Based Mammographic Breast Cancer Screening.
    Neal CH; Rahman WT; Joe AI; Noroozian M; Pinsky RW; Helvie MA
    AJR Am J Roentgenol; 2018 Jan; 210(1):228-234. PubMed ID: 29091007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
    Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
    Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
    Hofvind S; Møller B; Thoresen S; Ursin G
    Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
    Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
    Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.